Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jaromir Petrtyl, Karel Dvorak, Marie Jachymova, Libor Vitek, Martin Lenicek, PETR Urbanek, Ales Linhart, Pavel Jansa & Radan Bruha. (2013) Functional variants of eNOS and iNOS genes have no relationship to the portal hypertension in patients with liver cirrhosis. Scandinavian Journal of Gastroenterology 48:5, pages 592-601.
Read now
Read now
Radan Bruha, Libor Vitek, Jaromir Petrtyl, Martin Lenicek, Petr Urbanek, Jaroslav Zelenka, Marie Jachymova, Tomislav Svestka, Milan Kalab, Miroslav Dousa & Zdenek Marecek. (2006) Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes. Scandinavian Journal of Gastroenterology 41:12, pages 1454-1463.
Read now
Read now
Articles from other publishers (31)
Sara A. El-Mokhtar, Noha A. Afifi, Mohamed O. Abdel-Malek, Waleed A. Hassan, Helal Hetta & Omnia El-Badawy. (2023) Aberrant cytokine and VCAM-1 expression in patients with viral and non-viral related liver cirrhosis. Cytokine 171, pages 156385.
Crossref
Crossref
Wenjing Gou, Di Zhang & Lianyin Gao. (2023) Qingdu decoction can reduce LPS induced ACLF endotoxemia by regulating microRNA-34c/MAZ/TJs and microRNA-122a/Zonulin/EGFR signal pathway. Journal of Ethnopharmacology 302, pages 115922.
Crossref
Crossref
Victoria T. Kronsten, Thomas H. Tranah, Carmine Pariante & Debbie L. Shawcross. (2022) Gut-derived systemic inflammation as a driver of depression in chronic liver disease. Journal of Hepatology 76:3, pages 665-680.
Crossref
Crossref
Victoria Tatiana Kronsten & Debbie Lindsay Shawcross. (2022) Hepatic encephalopathy and depression in chronic liver disease: is the common link systemic inflammation?. Analytical Biochemistry 636, pages 114437.
Crossref
Crossref
Elena Curakova Ristovska. 2021. Portal Hypertension - Recent Advances. Portal Hypertension - Recent Advances.
Sumit Kar, Sabina Paglialunga, Sharon H. Jaycox, Rafiqul Islam & Angelo H. Paredes. (2019) Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis. PLOS ONE 14:7, pages e0217263.
Crossref
Crossref
Yoshito Itoh, Yuya Seko, Toshihide Shima, Tomoaki Nakajima, Kei Mizuno, Yusuke Kawamura, Norio Akuta, Kiyoaki Ito, Miwa Kawanaka, Akira Hiramatsu, Michiie Sakamoto, Kenichi Harada, Yoshihito Goto, Takeo Nakayama, Hiromitsu Kumada & Takeshi Okanoue. (2018) Accuracy of non‐invasive scoring systems for diagnosing non‐alcoholic steatohepatitis‐related fibrosis: Multicenter validation study. Hepatology Research 48:13, pages 1099-1107.
Crossref
Crossref
Tzu-Hao Li, Pei-Chang Lee, Kuei-Chuan Lee, Yun-Cheng Hsieh, Chang-Youh Tsai, Ying-Ying Yang, Shiang-Fen Huang, Tung-Hu Tsai, Shie-Liang Hsieh, Ming-Chih Hou, Han-Chieh Lin & Shou-Dong Lee. (2016) Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis. Scientific Reports 6:1.
Crossref
Crossref
Cristina Solé, Elsa Solà, Manuel Morales-Ruiz, Guerau Fernàndez, Patricia Huelin, Isabel Graupera, Rebeca Moreira, Gloria de Prada, Xavier Ariza, Elisa Pose, Núria Fabrellas, Susana G. Kalko, Wladimiro Jiménez & Pere Ginès. (2016) Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis. Scientific Reports 6:1.
Crossref
Crossref
Teresa Aldámiz-Echevarría, Juan Berenguer, Pilar Miralles, María A. Jiménez-Sousa, Ana Carrero, Daniel Pineda-Tenor, Cristina Díez, Francisco Tejerina, Leire Pérez-Latorre, José M. Bellón & Salvador Resino. (2016) Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome. PLOS ONE 11:2, pages e0148537.
Crossref
Crossref
Mercedes Márquez. (2016) Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity. World Journal of Gastroenterology 22:4, pages 1433.
Crossref
Crossref
Agustín Albillos, Margaret Lario & Melchor Álvarez-Mon. (2014) Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance. Journal of Hepatology 61:6, pages 1385-1396.
Crossref
Crossref
Sara Corchado, Luis F. López-Cortés, Antonio Rivero-Juárez, Almudena Torres-Cornejo, Antonio Rivero, Mercedes Márquez-Coello & José-Antonio Girón-González. (2014) Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients. PLoS ONE 9:7, pages e101760.
Crossref
Crossref
Sara Corchado, Mercedes Márquez, Montserrat Montes de Oca, Paula Romero-Cores, Clotilde Fernández-Gutiérrez & José-Antonio Girón-González. (2013) Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients. PLoS ONE 8:6, pages e66619.
Crossref
Crossref
Nasser M. Rizk & Moutaz F. Derbala. (2013) Genetic polymorphisms of ICAM 1 and IL28 as predictors of liver fibrosis severity and viral clearance in hepatitis C genotype 4. Clinics and Research in Hepatology and Gastroenterology 37:3, pages 262-268.
Crossref
Crossref
Antonio Diaz-Sanchez, Ana Matilla, Oscar Nuñez, Diego Rincon, Raquel Lorente, Oreste Lo lacono, Beatriz Merino, Ana Hernando, Rocio Campos, Gerardo Clemente & Rafael Bañares. (2013) Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease. Annals of Hepatology 12:2, pages 236-247.
Crossref
Crossref
Muhammad Y. Sheikh, Usman Javed, Jasjit Singh, Jayanta Choudhury, Omer Deen, Kulraj Dhah & Michael W. Peterson. (2009) Bedside Sublingual Video Imaging of Microcirculation in Assessing Bacterial Infection in Cirrhosis. Digestive Diseases and Sciences 54:12, pages 2706-2711.
Crossref
Crossref
Akiko Kamiyoshi, Takayuki Sakurai, Yuka Ichikawa‐Shindo, Nobuyoshi Iinuma, Hisaka Kawate, Takahiro Yoshizawa, Teruhide Koyama, Shin‐ichi Muto & Takayuki Shindo. (2009) Endogenous α‐calcitonin gene‐related peptide mitigates liver fibrosis in chronic hepatitis induced by repeated administration of concanavalin A. Liver International 29:5, pages 642-649.
Crossref
Crossref
J. Arranz Duran, A. Arteaga González, D. Domínguez García, R. Calvo Falcón, P. Sanz Pereda, J. Navarro, S. Méndez Alvárez, I. García Cobaleda, A. Aguirre Jaime, I. Arteaga González, A. Varona Bosque, M. Barrera Gómez & A. Soriano Benítez de Lugo. (2009) Best Blood Sample Draw Site During Liver Transplantation. Transplantation Proceedings 41:3, pages 991-993.
Crossref
Crossref
Jasper H. Smalberg & Frank W.G. Leebeek. (2009) Superimposed Coagulopathic Conditions in Cirrhosis: Infection and Endogenous Heparinoids, Renal Failure, and Endothelial Dysfunction. Clinics in Liver Disease 13:1, pages 33-42.
Crossref
Crossref
Frank Grünhage, Bettina Rezori, Markus Neef, Frank Lammert, Tilman Sauerbruch, Ulrich Spengler & Christoph Reichel. (2008) Elevated Soluble Tumor Necrosis Factor Receptor 75 Concentrations Identify Patients With Liver Cirrhosis at Risk of Death. Clinical Gastroenterology and Hepatology 6:11, pages 1255-1262.
Crossref
Crossref
Oreste Lo Iacono, Diego Rincón, Ana Hernando, Cristina Ripoll, Maria Vega Catalina, Magdalena Salcedo, Gerardo Clemente, Judith Gomez, Oscar Nuñez, Ana Matilla & Rafael Bañares. (2008) Serum levels of soluble vascular cell adhesion molecule are related to hyperdynamic circulation in patients with liver cirrhosis. Liver International 28:8, pages 1129-1135.
Crossref
Crossref
Frank Tacke, Christian Trautwein, Eray Yagmur, Claus Hellerbrand, Reiner Wiest, David A Brenner & Bernd Schnabl. (2007) Up‐regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course. Journal of Gastroenterology and Hepatology 22:8, pages 1256-1264.
Crossref
Crossref
Peng Lv, He-Sheng Luo, Xiao-Ping Zhou, Yan-Jv Xiao, Shelley Chireyath Paul, Xin-Min Si & Yan-Hong Zhou. (2007) Reversal Effect of Thalidomide on Established Hepatic Cirrhosis in Rats via Inhibition of Nuclear Factor-κB/Inhibitor of Nuclear Factor-κB Pathway. Archives of Medical Research 38:1, pages 15-27.
Crossref
Crossref
C-H Wang, T-H Lee, C-N Lu, W-Y Chou, K-S Hung, A M Concejero & B Jawan. (2006) Electroporative α-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation. Gene Therapy 13:13, pages 1000-1009.
Crossref
Crossref
Tsung‐Hsing Lee, Bruno Jawan, Wen‐Ying Chou, Cheng‐Nan Lu, Chia‐Ling Wu, Hsiao‐Mei Kuo, Allan M. Concejero & Cheng‐Haung Wang. (2006) α‐Melanocyte‐stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice. The Journal of Gene Medicine 8:6, pages 764-772.
Crossref
Crossref
Wen-ying CHOU, Cheng-nan LU, Tsung-hsing LEE, Chia-ling WU, Kung-sheng HUNG, Allan M CONCEJERO, Bruno JAWAN & Cheng-haung WANG. (2006) Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation1. Acta Pharmacologica Sinica 27:4, pages 469-476.
Crossref
Crossref
Anatol Panasiuk. (2006) Expression of β2-integrin on leukocytes in liver cirrhosis. World Journal of Gastroenterology 12:38, pages 6193.
Crossref
Crossref
Peng Lv, Shelley Chireyath Paul, Yanjv Xiao, Shiquan Liu & Hesheng Luo. (2006) Effects of Thalidomide on the Expression of Adhesion Molecules in Rat Liver Cirrhosis. Mediators of Inflammation 2006, pages 1-10.
Crossref
Crossref
Gennaro D'Amico, Guadalupe Garcia-Tsao & Luigi Pagliaro. (2006) Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. Journal of Hepatology 44:1, pages 217-231.
Crossref
Crossref
Kung-Sheng Hung, Tsung-Hsing Lee, Wen-Ying Chou, Chia-Ling Wu, Chung-Lung Cho, Cheng-Nan Lu, Bruno Jawan & Cheng-Haung Wang. (2005) Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice. Biochemical and Biophysical Research Communications 336:1, pages 324-331.
Crossref
Crossref